Dr. Michael Ormsbee

And I think like Stu Phillips has said that over and over in some of his work. And it's right.

And I think like Stu Phillips has said that over and over in some of his work. And it's right.

But for muscle, no, it's not where you want it. The amino acid profile isn't there. Right. So we were specifically looking at joint pain. That's what our outcome was. And it was in middle-aged and older, lifelong, active people. And so it was a fun time recruiting these individuals. Some golfed every day. Some ran every day. But some were elite CrossFitters. Some were triathletes.

But for muscle, no, it's not where you want it. The amino acid profile isn't there. Right. So we were specifically looking at joint pain. That's what our outcome was. And it was in middle-aged and older, lifelong, active people. And so it was a fun time recruiting these individuals. Some golfed every day. Some ran every day. But some were elite CrossFitters. Some were triathletes.

So all kinds of a range of people, but they're all active every single day. Or not every Sunday, but very active for recruiting purposes. And then we gave them either zero, 10 or 20 grams of collagen per day. And it was designed at six months. But as we were getting closer, we said, well, if we're doing it this long, let's see if we can keep them on and do nine months.

So all kinds of a range of people, but they're all active every single day. Or not every Sunday, but very active for recruiting purposes. And then we gave them either zero, 10 or 20 grams of collagen per day. And it was designed at six months. But as we were getting closer, we said, well, if we're doing it this long, let's see if we can keep them on and do nine months.

So maybe we can look at bone.

So maybe we can look at bone.

And then we're like, well, we probably need a year, but let's see if we can get nine months and see what's happening.

And then we're like, well, we probably need a year, but let's see if we can get nine months and see what's happening.

And so we were still underpowered at that point, unfortunately, for Bones. So we were still primarily focused on. It's like a maybe we get it. Yeah, we'll see.

And so we were still underpowered at that point, unfortunately, for Bones. So we were still primarily focused on. It's like a maybe we get it. Yeah, we'll see.

And so we offered the opportunity for the people who volunteered for six months to stay on for three more.

And so we offered the opportunity for the people who volunteered for six months to stay on for three more.

Yeah, like three months in we wrote to the funding agency and I said, I think we should extend this, but it's going to cost X amount to do that. Are you on board? And so they were on board with doing it. So we ended up extending it. And a couple of interesting things came from it.

Yeah, like three months in we wrote to the funding agency and I said, I think we should extend this, but it's going to cost X amount to do that. Are you on board? And so they were on board with doing it. So we ended up extending it. And a couple of interesting things came from it.

It was mostly questionnaires in our study because we were looking at joint pain and we tried to use like goniometers for range of motion and some of these other things. And we did some more high tech tools that we had, but they weren't working. There was too much variability in making that happen.

It was mostly questionnaires in our study because we were looking at joint pain and we tried to use like goniometers for range of motion and some of these other things. And we did some more high tech tools that we had, but they weren't working. There was too much variability in making that happen.

And also the researcher who was doing that was a doc student driving this work, Shloa Kiyokofsky, and she's at UAMS now. And Anyway, she's still carrying on the collagen line, so it's carried on in her lab now.

And also the researcher who was doing that was a doc student driving this work, Shloa Kiyokofsky, and she's at UAMS now. And Anyway, she's still carrying on the collagen line, so it's carried on in her lab now.